Vimarsana
Biggest News Aggregation in the World

Page 42 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Service Testing Today - Breaking & Trending Today

Candel Therapeutics Falls to 52-Week Low After Interim CAN-2409 Study Data - Vimarsana News

Candel Therapeutics Falls to 52-Week Low After Interim CAN-2409 Study Data

By Josh Beckerman Shares of Candel Therapeutics fell to a 52-week low after the cancer-focused biopharmaceutical company reported interim data from a...

TC BioPharm Inks Trial-Management Deal With Fortrea Amid Cost Cutting - Vimarsana News

TC BioPharm Inks Trial-Management Deal With Fortrea Amid Cost Cutting

By Ben Glickman TC BioPharm Holdings has reached a deal for Fortrea to manage its global clinical trials, the latest cost-cutting effort by the...

Kronos Bio to Cut 19% of Workforce in Bid to Extend Runway - Vimarsana News

Kronos Bio to Cut 19% of Workforce in Bid to Extend Runway

By Colin Kellaher Kronos Bio is shedding about 19% of its staff as the clinical-stage biopharmaceutical moves to extend its cash runway following positive...

Nurix Therapeutics Says FDA Places Partial Clinical Hold on NX-2127 Phase 1 Trial - Vimarsana News

Nurix Therapeutics Says FDA Places Partial Clinical Hold on NX-2127 Phase 1 Trial

By Stephen Nakrosis Nurix Therapeutics on Wednesday said the Food and Drug Administration placed a partial clinical hold on U.S. Phase 1 NX-2127-001 study...

Mersana Says FDA Lifts Clinical Hold on Gastric-Cancer Treatment Phase I Trial - Vimarsana News

Mersana Says FDA Lifts Clinical Hold on Gastric-Cancer Treatment Phase I Trial

By Rob Curran Biotech company Mersana Therapeutics said the Food and Drug Administration lifted a clinical hold on a Phase 1 trial of one of its...